News Sarepta DMD gene therapy could improve patients' motor funct... Sarepta Therapeutics announced potentially game-changing results from its Duchenne muscular dystrophy gene therapy candidate, with a small phase 1 trial showing an improvement in patients’
DMD Main Curing DMD: Travelling together to find a meaningful destina... For many years, Duchenne muscular dystrophy (DMD) was something of a forgotten disease.
Disease Spotlight Increase collaboration to widen access to DMD drugs, trials ... When it comes to fighting a rare disease like Duchenne muscular dystrophy (DMD), it’s a matter of strength in numbers.
News Pfizer axes development of Duchenne muscular dystrophy antib... Pfizer has axed trials of its domagrozumab antibody for Duchenne muscular dystrophy (DMD), after it failed against efficacy targets.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
